Biomarkers of doping: uses, discovery and validation
Related Experiment Video
Updated: Dec 20, 2025

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
Published on: January 28, 2014
Reid Aikin1, Norbert Baume1, Tristan Equey1
1World Anti-Doping Agency, 800 Rue du Square-Victoria Suite 1700, Montreal, QC H4Z 1B7, Canada.
Abstract:
A biomarker of doping indicates the biological response to the use of a prohibited substance or method. Uncovering novel biomarkers of doping is a key objective in order to improve antidoping outcomes such as the detection of doping and changing athlete behavior toward doping practices. While the antidoping field has been successful in validating novel metabolites of prohibited substances, there has been less success in developing new biomarkers of doping. Employing the most suitable study designs and analytical approaches is critical to successfully uncovering novel biomarkers of doping with a high potential for translation into routine analysis. Here we argue that the antidoping field is well positioned for biomarker discovery and outline considerations for the development of novel biomarkers of doping.
More Related Videos
Related Concept Videos
Drug Discovery: Overview
Therapeutic Drug Monitoring: Drug Analysis Methods
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Drug Concentrations: Measurements
Plasma...
DNA Microarrays

